Oshinowo O, Copeland R, Patel A, Shaver N, Fay M, Jeltuhin R
Nat Commun. 2024; 15(1):10201.
PMID: 39587073
PMC: 11589161.
DOI: 10.1038/s41467-024-54309-8.
Maaloul I, Kolsi R, Chaari M, Ameur S, Aloulou H, Kamoun T
Tunis Med. 2024; 102(11):916-921.
PMID: 39564636
PMC: 11668153.
DOI: 10.62438/tunismed.v102i11.5117.
Chowdhury S, Sirotich E, Guyatt G, Gill D, Modi D, Venier L
Eur J Haematol. 2024; 114(3):458-468.
PMID: 39552264
PMC: 11798764.
DOI: 10.1111/ejh.14351.
Nakano T, Grimes A, Klaassen R, Lambert M, Neunert C, Rothman J
Blood Adv. 2024; 8(19):5112-5117.
PMID: 39059013
PMC: 11460440.
DOI: 10.1182/bloodadvances.2024012707.
Mohamed Ragab S, Moustafa Abo ElFotoh W, Ahmed El-Hawy M, Abdelfatah Badr E, Khairat Ali Mostafa S, El-Sayad Abd El-Hamid M
Clin Exp Pediatr. 2024; 67(9):465-473.
PMID: 39054641
PMC: 11374454.
DOI: 10.3345/cep.2024.00577.
Prediction of the Clinical Course of Immune Thrombocytopenia in Children by Platelet Kinetics.
Lejeune J, Raoult V, Dubrasquet M, Chauvin R, Mallebranche C, Pellier I
Hemasphere. 2023; 7(11):e960.
PMID: 37908859
PMC: 10615561.
DOI: 10.1097/HS9.0000000000000960.
Cellular surface plasmon resonance-based detection of anti-HPA-1a antibody glycosylation in fetal and neonatal alloimmune thrombocytopenia.
Szittner Z, Bentlage A, Temming A, Schmidt D, Visser R, Lissenberg-Thunnissen S
Front Immunol. 2023; 14:1225603.
PMID: 37868955
PMC: 10585714.
DOI: 10.3389/fimmu.2023.1225603.
Recommendations for the management of acute immune thrombocytopenia in children. A Consensus Conference from the Italian Association of Pediatric Hematology and Oncology.
Russo G, Parodi E, Farruggia P, Notarangelo L, Perrotta S, Casale M
Blood Transfus. 2023; 22(3):253-265.
PMID: 37677093
PMC: 11073630.
DOI: 10.2450/BloodTransfus.501.
Severe immune thrombocytopenia that developed immediately after COVID-19 in a school-aged patient: A case report.
Shinno K, Banno Y, Kamimaki I
Front Pediatr. 2023; 11:1120093.
PMID: 37033169
PMC: 10073461.
DOI: 10.3389/fped.2023.1120093.
Immune thrombocytopenia in infants: a retrospective study with comparison to toddlers.
Lee A
Singapore Med J. 2023; 66(1):20-23.
PMID: 36926741
PMC: 11809746.
DOI: 10.4103/singaporemedj.SMJ-2021-184.
"CHildren with Inherited Platelet disorders Surveillance" (CHIPS) retrospective and prospective observational cohort study by Italian Association of Pediatric Hematology and Oncology (AIEOP).
Lassandro G, Palladino V, Faleschini M, Barone A, Boscarol G, Cesaro S
Front Pediatr. 2022; 10:967417.
PMID: 36507135
PMC: 9728612.
DOI: 10.3389/fped.2022.967417.
Platelet findings in 22q11.2 deletion syndrome correlate with disease manifestations but do not correlate with GPIb surface expression.
Campbell I, Crowley T, Jobaliya C, Bailey A, McGinn D, Gaiser K
Clin Genet. 2022; 103(1):109-113.
PMID: 36075864
PMC: 9742133.
DOI: 10.1111/cge.14227.
The Use of Clinical Scores in the Management of Immune Thrombocytopenic Purpura in Children.
Rosu V, Spoiala E, Rosu T, Ivanov A, Mocanu A, Munteanu A
Front Pediatr. 2022; 10:870064.
PMID: 35615630
PMC: 9125152.
DOI: 10.3389/fped.2022.870064.
Chronic Refractory Immune Thrombocytopenia Is Associated With Variants in Immune Genes.
Zhao S, Ma J, Zhu X, Zhang J, Wu R
Clin Appl Thromb Hemost. 2021; 27:10760296211059813.
PMID: 34786962
PMC: 8619729.
DOI: 10.1177/10760296211059813.
ESPED survey on newly diagnosed immune thrombocytopenia in childhood: how much treatment do we give?.
von Lukowicz H, Schlegel P, Hartel C, Morbach H, Haubitz I, Wiegering V
Mol Cell Pediatr. 2021; 8(1):11.
PMID: 34486084
PMC: 8419130.
DOI: 10.1186/s40348-021-00121-z.
Phase 3 randomised trial of eltrombopag versus standard first-line pharmacological management for newly diagnosed immune thrombocytopaenia (ITP) in children: study protocol.
Shimano K, Grace R, Despotovic J, Neufeld E, Klaassen R, Bennett C
BMJ Open. 2021; 11(8):e044885.
PMID: 34452956
PMC: 8404450.
DOI: 10.1136/bmjopen-2020-044885.
Biological stratification of clinical disease courses in childhood immune thrombocytopenia.
Schmidt D, Heitink-Polle K, Mertens B, Porcelijn L, Kapur R, van der Schoot C
J Thromb Haemost. 2021; 19(4):1071-1081.
PMID: 33386662
PMC: 8048469.
DOI: 10.1111/jth.15232.
Dapsone: An Old but Effective Therapy in Pediatric Refractory Immune Thrombocytopenia.
Khera S, Pramanik S, Yanamandra U, Mishra K, Kapoor R, Das S
Indian J Hematol Blood Transfus. 2020; 36(4):690-694.
PMID: 33100711
PMC: 7573006.
DOI: 10.1007/s12288-020-01286-9.
Predicting bleeding risk in a Chinese immune thrombocytopenia (ITP) population: development and assessment of a new predictive nomogram.
Wang M, Liu W, Xu Y, Wang H, Guo X, Ding X
Sci Rep. 2020; 10(1):15337.
PMID: 32948823
PMC: 7501260.
DOI: 10.1038/s41598-020-72275-1.
Platelet-specific antibodies and differences in their expression in childhood immune thrombocytopenic purpura predicts clinical progression.
Fu L, Ma J, Cheng Z, Gu H, Ma J, Wu R
Pediatr Investig. 2020; 2(4):230-235.
PMID: 32851271
PMC: 7331365.
DOI: 10.1002/ped4.12097.